A Small Nonprofit Becomes Powerful Drug Price Watchdog06:03
Download

Play

The independent Institute for Clinical and Economic Review uses a cost-benefit analysis to figure out fair drug prices. It's been called "Big Pharma's biggest threat." Carey Goldberg (@goldbergcarey) of WBUR reports.

This segment aired on July 15, 2019.

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news